397P R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer
Authors:
- J. CarrascoJCJ. Carrasco
- D. SchröderDSD. Schröder
- I. SinapiISI. Sinapi
- A. De CuyperACA. De Cuyper
- G. BeniugaGBG. Beniuga
- S. DelmarcelleSDS. Delmarcelle
- J-L. van LaethemJLJ-L. van Laethem
- N. HuygheNHN. Huyghe
- I. BarIBI. Bar
- A. HendliszAHA. Hendlisz
- K.M. HaustermansKHK.M. Haustermans
- T. DelaunoitTDT. Delaunoit
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 32, S537